The board overseeing the NIH Clinical Center wrote a letter to HHS Secretary Robert F. Kennedy Jr., saying his increased ...
The findings on the triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1) ...
Emmy-winning actor Christina Applegate revealed this week that her doctor said her diagnosis of multiple sclerosis (MS), ...
Long-acting injectable antiretroviral therapy (ART) maintained virologic suppression for HIV patients, with virologic failure ...
ICU length of stay remained stable at an average of 5 days, and ventilator utilization was unchanged as well, reported ...
Published findings indicate that it was met, but less impressive results for secondary outcomes raise questions about its true efficacy; ianalumab's sponsor has commenced a new phase III trial.
A Salmonella outbreak linked to raw oysters has sickened 27 people and hospitalized five across a dozen states, the CDC said.
A gene rearrangement is referred to as "a hit," Westin told MedPage Today, adding that in the case of double-hit lymphoma, ...
TOLEDO, Ohio -- A ruptured chemical tank billowed a white plume into the air for hours Wednesday, forcing hundreds of residents out of their homes due to fears of a toxic release and the possibility ...
In babies who don't get a birth dose, ACIP recommended delaying the first dose of the three-dose series to at least age 2 ...
Testosterone therapy for menopause was linked to heightened risk of incident cardiovascular disease, a large retrospective cohort study suggested. Over 5 years, testosterone therapy during menopause ...
Although blocking a suspicious prescriber can prevent further unsafe dispensing of controlled substances, its clinical benefit also depends on whether patients subsequently receive appropriate care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results